These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9008597)

  • 1. Long-term treatment of systemic lupus erythematosus with cyclosporin A.
    Caccavo D; Laganà B; Mitterhofer AP; Ferri GM; Afeltra A; Amoroso A; Bonomo L
    Arthritis Rheum; 1997 Jan; 40(1):27-35. PubMed ID: 9008597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.
    Manger K; Kalden JR; Manger B
    Br J Rheumatol; 1996 Jul; 35(7):669-75. PubMed ID: 8670602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.
    Dostál C; Tesar V; Rychlík I; Zabka J; Vencovský J; Bartûnková J; Stejskalová A; Tegzova D
    Lupus; 1998; 7(1):29-36. PubMed ID: 9493146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity.
    Tokuda M; Kurata N; Mizoguchi A; Inoh M; Seto K; Kinashi M; Takahara J
    Arthritis Rheum; 1994 Apr; 37(4):551-8. PubMed ID: 8147933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
    Ogawa H; Kameda H; Amano K; Takeuchi T
    Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis.
    Sarzi-Puttini P; Cazzola M; Panni B; Turiel M; Fiorini T; Belai-Beyene N; Chèrié-Lignièré EL
    Rheumatol Int; 2002 Apr; 21(6):234-8. PubMed ID: 12036210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A.
    Conti F; Priori R; Alessandri C; Spinelli FR; Medda E; Valesini G
    Lupus; 2000; 9(9):676-80. PubMed ID: 11199922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A in the long-term management of systemic lupus erythematosus.
    Germano V; Picchianti Diamanti A; Ferlito C; Podestà E; Salemi S; Migliore A; D' Amelio R; Laganà B
    J Biol Regul Homeost Agents; 2011; 25(3):397-403. PubMed ID: 22023764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
    Tarr T; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2005 Dec; 146(49):2485-9. PubMed ID: 16398313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
    Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
    Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use.
    Morton SJ; Powell RJ
    Ann Rheum Dis; 2000 Jun; 59(6):487-9. PubMed ID: 10834868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosus.
    Wada Y; Kotani T; Takeuchi T; Wakura R; Wakura D; Makino S; Hanafusa T
    Mod Rheumatol; 2015 Sep; 25(5):708-13. PubMed ID: 25835315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of lupus nephritis with cyclosporin A.
    Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF
    QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A in treatment of membranous lupus nephropathy.
    Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
    Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report.
    Wang SW; Cheng TT
    Lupus; 2005; 14(6):483-5. PubMed ID: 16038113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of lupus with cyclosporin A.
    Griffiths B; Emery P
    Lupus; 2001; 10(3):165-70. PubMed ID: 11315347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.